Interparfums (IPAR) Competitors

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 42.4% of Coty shares are owned by institutional investors. 43.7% of Interparfums shares are owned by company insiders. Comparatively, 5.9% of Coty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Interparfums presently has a consensus price target of $106.00, suggesting a potential upside of 6.97%. Coty has a consensus price target of $3.70, suggesting a potential upside of 90.41%. Given Coty's higher probable upside, analysts clearly believe Coty is more favorable than Interparfums.

Interparfums has higher earnings, but lower revenue than Coty. Coty is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

In the previous week, Coty had 3 more articles in the media than Interparfums. MarketBeat recorded 3 mentions for Coty and 0 mentions for Interparfums. Coty's average media sentiment score of 0.87 beat Interparfums' score of 0.00 indicating that Coty is being referred to more favorably in the news media.

Interparfums has a net margin of 11.32% compared to Coty's net margin of -9.20%. Interparfums' return on equity of 15.47% beat Coty's return on equity.

Interparfums has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market. Comparatively, Coty has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.

Interparfums has higher earnings, but lower revenue than e.l.f. Beauty. Interparfums is trading at a lower price-to-earnings ratio than e.l.f. Beauty, indicating that it is currently the more affordable of the two stocks.

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 92.4% of e.l.f. Beauty shares are owned by institutional investors. 43.7% of Interparfums shares are owned by insiders. Comparatively, 3.9% of e.l.f. Beauty shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, e.l.f. Beauty had 15 more articles in the media than Interparfums. MarketBeat recorded 15 mentions for e.l.f. Beauty and 0 mentions for Interparfums. e.l.f. Beauty's average media sentiment score of 1.05 beat Interparfums' score of 0.00 indicating that e.l.f. Beauty is being referred to more favorably in the news media.

Interparfums currently has a consensus target price of $106.00, suggesting a potential upside of 6.97%. e.l.f. Beauty has a consensus target price of $78.31, suggesting a potential upside of 21.97%. Given e.l.f. Beauty's higher possible upside, analysts plainly believe e.l.f. Beauty is more favorable than Interparfums.

Interparfums has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market. Comparatively, e.l.f. Beauty has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market.

Interparfums has a net margin of 11.32% compared to e.l.f. Beauty's net margin of 1.61%. Interparfums' return on equity of 15.47% beat e.l.f. Beauty's return on equity.

In the previous week, Lamb Weston had 7 more articles in the media than Interparfums. MarketBeat recorded 7 mentions for Lamb Weston and 0 mentions for Interparfums. Lamb Weston's average media sentiment score of 1.20 beat Interparfums' score of 0.00 indicating that Lamb Weston is being referred to more favorably in the media.

89.6% of Lamb Weston shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 0.3% of Lamb Weston shares are held by company insiders. Comparatively, 43.7% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Lamb Weston pays an annual dividend of $1.52 per share and has a dividend yield of 3.4%. Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 3.2%. Lamb Weston pays out 71.0% of its earnings in the form of a dividend. Interparfums pays out 60.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Lamb Weston has increased its dividend for 7 consecutive years and Interparfums has increased its dividend for 4 consecutive years. Lamb Weston is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Interparfums has a net margin of 11.32% compared to Lamb Weston's net margin of 4.61%. Lamb Weston's return on equity of 23.77% beat Interparfums' return on equity.

Lamb Weston has higher revenue and earnings than Interparfums. Interparfums is trading at a lower price-to-earnings ratio than Lamb Weston, indicating that it is currently the more affordable of the two stocks.

Lamb Weston currently has a consensus price target of $47.82, indicating a potential upside of 6.03%. Interparfums has a consensus price target of $106.00, indicating a potential upside of 6.97%. Given Interparfums' stronger consensus rating and higher probable upside, analysts plainly believe Interparfums is more favorable than Lamb Weston.

Lamb Weston has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

Medifast currently has a consensus target price of $12.00, suggesting a potential upside of 8.42%. Interparfums has a consensus target price of $106.00, suggesting a potential upside of 6.97%. Given Medifast's higher probable upside, equities analysts clearly believe Medifast is more favorable than Interparfums.

Interparfums has a net margin of 11.32% compared to Medifast's net margin of -5.78%. Interparfums' return on equity of 15.47% beat Medifast's return on equity.

Interparfums has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

In the previous week, Medifast's average media sentiment score of 0.00 equaled Interparfums'average media sentiment score.

Medifast has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

95.5% of Medifast shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 3.7% of Medifast shares are owned by insiders. Comparatively, 43.7% of Interparfums shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.